# A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN)

> **NCT05764161** · PHASE3 · COMPLETED · sponsor: **Incyte Corporation** · enrollment: 190 (actual)

## Conditions studied

- Prurigo Nodularis

## Interventions

- **DRUG:** Ruxolitinib Cream
- **DRUG:** Vehicle Cream

## Key facts

- **NCT ID:** NCT05764161
- **Lead sponsor:** Incyte Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-12
- **Primary completion:** 2024-12-30
- **Final completion:** 2025-11-04
- **Target enrollment:** 190 (ACTUAL)
- **Last updated:** 2025-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05764161

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05764161, "A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05764161. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*